Webinars

Our experts explain the key points of an SDS to be diffused in the European Union, as well as the new requirements for the year 2023, in order to avoid pitfalls when creating your document.

In this webinar, we will discuss the obligations according to the different roles in the supply chain, we will also guide you through the different steps in order to perform the SCIP notification.

Biocidal active substances are called in situ generated active substances if they are generated from one or more precursors at the place of use. The approval of these substances requires evaluation of the generated active substance and of the precursor(s) it is generated from, in the context of each product type (PT).

All biocidal products must comply with certain regulatory provisions before being placed on the European market (Biocidal Products Regulation 528/2012). They depend on the status of the active substance, the product type (PT) and the Member State(s) in which the biocidal product will be made available.

After Brexit on 31 January 2020, the UK entered a time limited transition period until 31st of December 2020. As the transition period has ended, regulation is an autonomous matter for both the UK and the EU as 2 separate legal and regulatory systems.

Companies must register substances and, in order to do so, collaborate with other companies that register the same substances. In this webinar, we will review the principles of REACH registration, explaining the scope, progress and obligations in the supply chain.